A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells. (Q47307094)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 December 2017
edit
Language Label Description Also known as
English
A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
scientific article published on 7 December 2017

    Statements

    An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit